United Statesbetween News Today

Both ENVISION and ATLAS Phase 3 trials of UGN-102 met primary endpoints in treating low-grade intermediate-risk non‐muscle‐invasive bladder cancer . Reported record JELMYTO® net product... -Today at 08:05 am- MarketScreener

Price increases have eased since 2022, but rent hikes continue nationwide. Small to midsize cities, from Mobile to Madison, were most affected in 2023.

Gallup survey data shows that, back in the 80's and 90's, the environment was the clear winner in the debate over whether it should be prioritised over eco